Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Adaptimmune Therapeutics plc (ADAP)

4.52   0.03 (0.67%) 01-17 16:00
Open: 4.51 Pre. Close: 4.49
High: 4.82 Low: 4.3
Volume: 1,885,690 Market Cap: 475M
Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.823 - 4.837 4.837 - 4.853
Low: 4.26 - 4.276 4.276 - 4.294
Close: 4.491 - 4.516 4.516 - 4.544

Technical analysis

as of: 2020-01-17 4:33:38 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 7.01     One year: 8.19
Support: Support1: 3.00    Support2: 1.15
Resistance: Resistance1: 6.00    Resistance2: 7.01
Pivot: 2.27
Moving Average: MA(5): 4.30     MA(20): 2.04
MA(100): 1.39     MA(250): 2.85
MACD: MACD(12,26): 0.79     Signal(9): 0.43
Stochastic oscillator: %K(14,3): 68.73     %D(3): 65.61
RSI: RSI(14): 93.05
52-week: High: 6.00  Low: 0.71  Change(%): -0.2
Average Vol(K): 3-Month: 183654  10-Days: 890211

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ADAP has closed below upper band by 10.9%. Bollinger Bands are 734.1% wider than normal. The large width of the bands suggest high volatility as compared to ADAP's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 14.) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ): announced an oncology stem cell therapy pact with Astellas Pharma Inc. (OTC: ALPMY ). Applied Therapeutics Inc (NASDAQ: APLT ) Arvinas Inc (NASDAQ: ARVN ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Calithera Biosciences Inc (NASDAQ: CALA ) Editas Medicine Inc (NASDAQ: EDIT ) Eli Lilly And Co (NYSE: LLY ) Epizyme Inc (NASDAQ: EPZM ) Fate Therapeutics Inc (NASDAQ: FATE ) Frequency Therapeutics Inc (NASDAQ: FREQ ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) (provided 2020 guidance) Hologic, Inc. (NASDAQ: HOLX ) Medpace Holdings Inc (NASDAQ: MEDP ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Myokardia Inc (NASDAQ: MYOK ) NeoGenomics, Inc. (NASDAQ: NEO ) Novo Nordisk A/S (NYSE: NVO ) NuVasive, Inc. (NASDAQ: NUVA ) Profound Medical Corp (NASDAQ: PROF ) Repligen Corporation (NASDAQ: RGEN ) Replimune Group Inc (NASDAQ: REPL ) Revance Therapeutics Inc (NASDAQ: RVNC ) Syneos Health, Inc. (NASDAQ: SYNH ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Varian Medical Systems, Inc. (NYSE: VAR ) Viela Bio Inc (NASDAQ: VIE ) West Pharmaceutical Services Inc. (NYSE: WST ) XBiotech Inc (NASDAQ: XBIT ) (announced a tender offer to buy up to $420 million worth …

Adaptimmune Soars 250% On Positive Initial Responses For T-Cell Platform In 4 Tumor Types
Shares of smid-cap biotech Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) were skyrocketing Monday following a presentation at the 38t

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 105.17
Shares Float (M) 53.23
% Held by Insiders 0.25
% Held by Institutions 71.92
Shares Short (K) 2620
Shares Short P. Month (K)

Stock Financials

EPS -1.391
Book Value (p.s.) 1.400
PEG Ratio -0.90
Profit Margin
Operating Margin -7555.85
Return on Assets (ttm) -34.2
Return on Equity (ttm) -67.9
Qtrly Rev. Growth -99.4
Gross Profit (p.s.) -0.369
Sales Per Share
EBITDA (p.s.) -1.269
Qtrly Earnings Growth
Operating Cash Flow (M) -131.66
Levered Free Cash Flow (M) -85.61

Stock Valuations

P/E -3.25
P/E Growth Ratio 0.01
P/BV 3.23
P/S 226.00
P/CF -3.61

Dividends & Splits

Dividend Yield
Dividend Pay Date 2018-03-30
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.